What is Aemetis, Inc. (DE)'s earnings per share (EPS)?

Aemetis, Inc. (DE) (AMTX) reported diluted earnings per share of -$1.28 for fiscal year 2025. This represents a 33.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Aemetis, Inc. (DE) (AMTX) Financials

AMTX

Trailing 12 months to June 30, 2026

Revenue $219.8M -1.7% YoY

Net Income -$60.2M +26.7% YoY

EPS (Diluted) -$0.87 +44.6% YoY

Free Cash Flow -$39.3M +1.1% YoY

Market Cap $124.1M as of Oct 2, 2026

Price / Sales 0.6x on $219.8M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMTX SEC filings page.

Aemetis, Inc. (DE) (AMTX) reported $219.8M in revenue over the twelve months to Jun 30, 2026, down 1.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMTX FY2025 2026-08-29

Financing dependence dominates Aemetis's model as capital investment continues despite negative equity and persistently thin margins.

The latest year paired positive operating cash flow of $3.3M with -$77.0M of net income, indicating that non-cash and working-capital effects—not reported earnings—drove the cash improvement. Meanwhile, capital intensity remained absorbing: $26.0M of capital expenditures left free cash flow at -$22.7M, so operating cash did not fund reinvestment.

Balance-sheet fragility is the central operating constraint: liabilities of $566.7M exceeded assets of $259.8M, leaving equity negative and the company structurally liability-heavy. A current ratio of 0.1 means current assets were only a small fraction of current liabilities, making external financing an important part of the business mechanics.

Revenue fell 26.2% year over year, yet the operating loss narrowed, showing cost absorption improved modestly even without top-line momentum. Because gross margin remained negative, that improvement reflects expense control or reduced fixed-cost pressure rather than a healthier core margin structure.

Financial Health Signals

Financial Health Score 33/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Aemetis, Inc. (DE)'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Aemetis, Inc. (DE) held $4.9M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $3.3M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Aemetis, Inc. (DE) scores 86/100 among other emerging companies.

Dilution

Aemetis, Inc. (DE) had 67M shares outstanding at the end of fiscal year 2025, against 53M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Aemetis, Inc. (DE) scores 30/100 among other emerging companies.

R&D Intensity

Not available for Aemetis, Inc. (DE), and counted as zero in the overall score.

Revenue Progress

Aemetis, Inc. (DE) reported revenue of $197.6M in fiscal year 2025, against $267.6M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Aemetis, Inc. (DE) scores 81/100 among other emerging companies.

Burn Trend

Not available for Aemetis, Inc. (DE), and counted as zero in the overall score.

Balance Sheet

Aemetis, Inc. (DE)'s cash, cash equivalents and investments came to $4.9M at the end of fiscal year 2025, against $566.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Aemetis, Inc. (DE) scores 2/100 among other emerging companies.

Altman Z-Score Distress

-4.62

Aemetis, Inc. (DE) scores -4.62, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($124.1M) relative to total liabilities ($566.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

4/9

Aemetis, Inc. (DE) passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

N/A

Aemetis, Inc. (DE) reported a net loss of $77.0M while generating $3.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Aemetis, Inc. (DE) reported an operating loss of $37.2M against $52.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$62.7M

YoY+20.0%

QoQ+14.8%

Aemetis, Inc. (DE) generated $62.7M in revenue in Q2 2026. This represents an increase of 20.0% from the same quarter a year earlier. Against the prior quarter it is up 14.8%.

EBITDA

$8.3M

YoY+200.4%

QoQ+318.9%

Aemetis, Inc. (DE)'s EBITDA was $8.3M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 200.4% from the same quarter a year earlier. Against the prior quarter it is up 318.9%.

Net Income

-$9.4M

YoY+60.0%

QoQ+56.9%

Aemetis, Inc. (DE) reported -$9.4M in net income in Q2 2026. This represents an increase of 60.0% from the same quarter a year earlier. Against the prior quarter it is up 56.9%.

EPS (Diluted)

-$0.13

YoY+68.3%

QoQ+60.6%

Aemetis, Inc. (DE) earned -$0.13 per diluted share (EPS) in Q2 2026. This represents an increase of 68.3% from the same quarter a year earlier. Against the prior quarter it is up 60.6%.

Cash & Balance Sheet

Free Cash Flow

-$10.4M

YoY-12.5%

QoQ+39.1%

Aemetis, Inc. (DE) recorded an outflow of $10.4M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 12.5% from the same quarter a year earlier. Against the prior quarter it is up 39.1%.

Cash & Debt

$973K

YoY-40.9%

QoQ-79.7%

5Y CAGR-32.9%

10Y CAGR+5.1%

Aemetis, Inc. (DE) held $973K in cash against $61.7M in long-term debt as of Q2 2026.

Shares Outstanding

72M

YoY+14.1%

QoQ+2.6%

5Y CAGR+16.8%

10Y CAGR+13.8%

Aemetis, Inc. (DE) had 72M shares outstanding in Q2 2026. This represents an increase of 14.1% from the same quarter a year earlier. Against the prior quarter it is up 2.6%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

21.6%

YoY+28.0pp

QoQ+16.5pp

Aemetis, Inc. (DE)'s gross margin was 21.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 28.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 16.5 percentage points.

Operating Margin

9.2%

YoY+29.6pp

QoQ+20.8pp

Aemetis, Inc. (DE)'s operating margin was 9.2% in Q2 2026, reflecting core business profitability. This is up 29.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 20.8 percentage points.

Net Margin

-14.9%

YoY+29.8pp

QoQ+24.8pp

Aemetis, Inc. (DE)'s net profit margin was -14.9% in Q2 2026, showing the share of revenue converted to profit. This is up 29.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 24.8 percentage points.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$8.5M

YoY+142.1%

QoQ+30.3%

5Y CAGR+6.0%

10Y CAGR+57.3%

Aemetis, Inc. (DE) invested $8.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 142.1% from the same quarter a year earlier. Against the prior quarter it is up 30.3%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

AMTX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMTX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$219.8M	$197.6M-26.2%	$267.6M+246.7%	$77.2M-69.9%	$256.5M+21.0%	$211.9M+28.0%	$165.6M-18.0%	$202.0M+17.8%	$171.5M+14.2%	$150.2M+4.9%	$143.2M-2.4%	$146.6M-29.4%	$207.7M+17.0%	$177.5M-6.1%	$189.0M+33.3%	$141.9M
Cost of Revenue	$206.2M	$208.7M-22.2%	$268.2M+45.2%	$184.7M-29.5%	$262.0M+28.4%	$204.0M+32.0%	$154.5M-18.4%	$189.3M+14.0%	$166.1M+13.2%	$146.8M+11.6%	$131.6M-7.6%	$142.4M-16.5%	$170.5M+7.1%	$159.2M-19.6%	$198.0M+44.3%	$137.2M
Gross Profit	$13.6M	-$768K-32.4%	-$580K+99.5%	-$107.5M-1842.3%	-$5.5M-169.7%	$7.9M-28.0%	$11.0M-13.2%	$12.7M+134.9%	$5.4M+60.1%	$3.4M-70.9%	$11.6M+176.2%	$4.2M-88.7%	$37.1M+103.0%	$18.3M+304.9%	-$8.9M-292.3%	$4.6M
R&D Expenses	N/A	N/A	N/A	$152K-15.6%	$180K+104.5%	$88K-58.7%	$213K+3.9%	$205K-16.7%	$246K-89.6%	$2.4M+541.5%	$369K-17.4%	$447K-2.6%	$459K-14.8%	$539K-13.1%	$620K+7.5%	$577K
SG&A Expenses	$35.5M	$36.5M-8.5%	$39.8M+1.1%	$39.4M+37.4%	$28.7M+21.2%	$23.7M+40.2%	$16.9M-3.1%	$17.4M+8.3%	$16.1M+21.9%	$13.2M+9.8%	$12.0M-2.8%	$12.4M-1.9%	$12.6M-17.5%	$15.3M+31.5%	$11.6M+35.5%	$8.6M
Operating Income	-$11.6M	-$37.2M+7.9%	-$40.4M-8.1%	-$37.4M-8.7%	-$34.4M-117.4%	-$15.8M-160.7%	-$6.1M-23.1%	-$4.9M+54.9%	-$10.9M+10.3%	-$12.2M-1459.9%	-$781K+90.9%	-$8.6M-135.7%	$24.1M+871.4%	$2.5M+111.7%	-$21.2M-369.7%	-$4.5M
EBITDA	N/A	-$27.6M+13.8%	-$32.0M-5.8%	-$30.3M-5.7%	-$28.6M-174.7%	-$10.4M-791.0%	-$1.2M-120.3%	-$531K+91.4%	-$6.2M+13.4%	-$7.2M-278.6%	$4.0M+207.1%	-$3.8M-113.0%	$28.9M+306.1%	$7.1M+139.3%	-$18.1M-438.5%	-$3.4M
Interest Expense	$54.9M	$52.9M+13.5%	$46.6M+18.0%	$39.5M+37.4%	$28.8M+19.6%	$24.1M+4.9%	$22.9M+8.8%	$21.1M-17.9%	$25.7M+33.1%	$19.3M+12.1%	$17.2M+69.4%	$10.2M+1.1%	$10.1M-14.9%	$11.8M-33.1%	$17.7M+30.2%	$13.6M
Income Tax	-$11.6M	-$18.7M-73.1%	-$10.8M+79.8%	-$53.7M-5203.1%	$1.1M+922.7%	-$128K+86.9%	-$976K-186.3%	$1.1M+16057.1%	$7K+16.7%	$6K0.0%	$6K0.0%	$6K0.0%	$6K0.0%	$6K+100.6%	-$1.1M-1034.6%	-$95K
Net Income	-$60.2M	-$77.0M+12.0%	-$87.5M-88.6%	-$46.4M+56.9%	-$107.8M-128.6%	-$47.1M-28.6%	-$36.7M+7.1%	-$39.5M-8.8%	-$36.3M-14.2%	-$31.8M-103.2%	-$15.6M+42.4%	-$27.1M-480.5%	$7.1M+129.2%	-$24.4M-470.7%	-$4.3M+76.6%	-$18.3M
EPS (Basic)	N/A	-$1.28+33.0%	-$1.91-56.6%	-$1.22+60.9%	-$3.12-102.6%	-$1.54+11.5%	-$1.74+0.6%	-$1.75-7.4%	-$1.63-6.5%	-$1.53-93.7%	-$0.79+42.3%	-$1.37-491.4%	$0.35+127.3%	-$1.28-357.1%	-$0.28-55.6%	-$0.18
EPS (Diluted)	-$0.87	-$1.28+33.0%	-$1.91-56.6%	-$1.22+60.9%	-$3.12-102.6%	-$1.54+11.5%	-$1.74+0.6%	-$1.75-7.4%	-$1.63-6.5%	-$1.53-93.7%	-$0.79+42.3%	-$1.37-502.9%	$0.34	-$1.28-357.1%	-$0.28	-$0.18
Diluted Shares (Avg)	N/A	60M+30.7%	46M+20.6%	38M+10.1%	35M+12.7%	31M+46.0%	21M+2.7%	20M+100961.6%	20,252+2.1%	19,833+0.3%	19,771-0.3%	19,823-5.8%	21,047	19,101+26.5%	15,102	104M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$62.7M+20.0%	$54.6M+27.4%	$43.3M-7.9%	$59.2M-27.3%	$52.2M-21.5%	$42.9M-41.0%	$47.0M	$81.4M+18.6%
Cost of Revenue	$49.2M-11.5%	$51.9M+8.1%	$45.9M-6.3%	$59.2M-23.6%	$55.6M-18.7%	$48.0M-34.5%	$49.0M	$77.6M+13.7%
Gross Profit	$13.5M+502.8%	$2.8M+154.3%	-$2.6M-28.9%	-$58K-101.5%	-$3.4M-85.8%	-$5.1M-730.1%	-$2.0M	$3.9M+688.2%
SG&A Expenses	$7.7M+5.8%	$9.1M-13.2%	$10.2M-10.8%	$8.4M+9.0%	$7.3M-38.0%	$10.5M+18.4%	$11.4M	$7.8M-14.1%
Operating Income	$5.8M+154.1%	-$6.3M+59.3%	-$2.5M+81.6%	-$8.5M-119.7%	-$10.7M+21.5%	-$15.6M-64.4%	-$13.5M	-$3.9M+54.6%
EBITDA	$8.3M+200.4%	-$3.8M+71.1%	-$4K+100.0%	-$6.2M-295.2%	-$8.3M+28.1%	-$13.2M-72.6%	-$11.3M	-$1.6M+76.9%
Interest Expense	$13.7M+10.8%	$14.4M+5.0%	$13.9M+10.3%	$12.9M+10.2%	$12.3M+5.2%	$13.7M+30.2%	$12.6M	$11.7M+15.4%
Income Tax	$0+100.0%	-$131K+98.1%	-$11.4M+7.5%	$6K-97.8%	-$529K-237.4%	-$6.8M-872.6%	-$12.4M	$274K+100.5%
Net Income	-$9.4M+60.0%	-$21.7M+11.5%	-$5.3M+67.1%	-$23.7M-32.4%	-$23.4M+19.8%	-$24.5M-1.2%	-$16.2M	-$17.9M-158.4%
EPS (Basic)	-$0.13+68.3%	-$0.33+29.8%	-$0.04+87.1%	-$0.37+2.6%	-$0.41+37.9%	-$0.47+19.0%	-$0.31+53.0%	-$0.38-148.1%
EPS (Diluted)	-$0.13+68.3%	-$0.33+29.8%	-$0.04	-$0.37+2.6%	-$0.41+37.9%	-$0.47+19.0%	-$0.31+53.0%	-$0.38-152.1%
Diluted Shares (Avg)	71M+22.9%	67M+27.0%	N/A	64M+34.9%	58M+29.9%	53M+25.5%	N/A	47M+12.8%

Not reported in any period shown, so not listed: R&D Expenses.

AMTX Balance Sheet

AMTX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$259.8M+0.2%	$259.3M+6.5%	$243.4M+17.5%	$207.1M+28.8%	$160.8M+28.5%	$125.1M+25.3%	$99.9M+8.8%	$91.8M-2.7%	$94.3M+21.2%	$77.8M-6.4%	$83.1M-6.8%	$89.2M-8.2%	$97.1M+0.3%	$96.9M+255.9%	$27.2M
Current Assets	$26.9M-39.9%	$44.7M+22.8%	$36.4M+100.7%	$18.1M-12.4%	$20.7M+138.3%	$8.7M-31.0%	$12.6M+22.0%	$10.3M-10.0%	$11.5M+62.7%	$7.0M-12.0%	$8.0M+0.9%	$7.9M-37.6%	$12.7M+85.6%	$6.8M-4.0%	$7.1M
Cash & Equivalents	$4.9M+445.0%	$898K-66.3%	$2.7M-38.2%	$4.3M-44.4%	$7.8M+1209.3%	$592K-9.8%	$656K-44.8%	$1.2M+177.6%	$428K-71.2%	$1.5M+425.1%	$283K-14.8%	$332K-93.3%	$4.9M+1592.8%	$291K+16.9%	$249K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$11.6M-54.3%	$25.4M+39.1%	$18.3M+292.7%	$4.7M-9.1%	$5.1M+29.2%	$4.0M-39.1%	$6.5M+6.3%	$6.1M+6.8%	$5.7M+77.0%	$3.2M-32.5%	$4.8M+7.0%	$4.5M+9.6%	$4.1M-10.0%	$4.6M+14.4%	$4.0M
Accounts Receivable	$500K-72.2%	$1.8M-79.1%	$8.6M+580.4%	$1.3M-19.7%	$1.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$968K	N/A	N/A	N/A
Total Liabilities	$566.7M+8.3%	$523.2M+13.7%	$460.4M+12.6%	$409.0M+45.5%	$281.1M-9.3%	$309.9M+21.9%	$254.3M+22.6%	$207.4M+20.1%	$172.7M+35.3%	$127.6M+7.8%	$118.4M+28.5%	$92.1M-16.2%	$109.9M+17.7%	$93.4M+88.9%	$49.4M
Current Liabilities	$371.3M+157.9%	$144.0M+70.6%	$84.4M-4.4%	$88.3M+35.1%	$65.3M-36.1%	$102.2M+76.8%	$57.8M+35.8%	$42.6M+18.2%	$36.0M+32.3%	$27.2M-7.1%	$29.3M+7.3%	$27.3M-24.4%	$36.1M-37.6%	$57.8M+96.5%	$29.4M
Non-Current Liabilities	$195.4M-48.5%	$379.3M+0.9%	$376.0M+17.2%	$320.7M+48.6%	$215.7M+3.9%	$207.6M+5.7%	$196.4M+19.2%	$164.8M+19.3%	$138.2M+37.6%	$100.4M+12.6%	$89.1M+37.5%	$64.8M-12.1%	$73.8M+107.7%	$35.5M+77.7%	$20.0M
Long-Term Debt	$63.9M-74.2%	$247.5M-3.9%	$257.7M+30.8%	$197.0M+18.7%	$166.0M-2.4%	$170.1M-5.3%	$179.7M+13.9%	$157.8M+14.2%	$138.2M+37.7%	$100.3M+12.8%	$88.9M+37.8%	$64.6M-12.5%	$73.8M+184.3%	$26.0M+29.8%	$20.0M
Total Equity	-$306.8M-16.3%	-$263.9M-21.6%	-$217.0M-7.5%	-$201.9M-67.9%	-$120.2M+34.9%	-$184.7M-19.7%	-$154.4M-33.6%	-$115.6M-47.4%	-$78.4M-57.4%	-$49.8M-41.1%	-$35.3M-1087.6%	-$3.0M+76.7%	-$12.8M-463.3%	$3.5M+115.8%	-$22.2M
Retained Earnings	-$639.9M-13.7%	-$562.9M-18.4%	-$475.4M-10.8%	-$429.0M-33.5%	-$321.2M-17.2%	-$274.1M-15.4%	-$237.4M-22.9%	-$193.2M-20.6%	-$160.2M-23.3%	-$129.9M-13.7%	-$114.3M-31.2%	-$87.1M+7.6%	-$94.2M-35.0%	-$69.8M-6.5%	-$65.5M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$289.2M+20.5%	$270.3M+4.0%	$259.8M+0.2%	$241.1M-7.0%	$240.0M-7.4%	$259.8M+0.2%	$259.3M+6.5%	$259.3M-6.5%
Current Assets	$33.0M+64.3%	$34.7M+21.7%	$26.9M-39.9%	$15.6M-55.4%	$20.1M-15.8%	$28.5M-13.5%	$44.7M+22.8%	$34.9M-55.5%
Cash & Equivalents	$973K-40.9%	$4.8M+861.3%	$4.9M+445.0%	$5.6M+1786.5%	$1.6M+603.0%	$499K-69.4%	$898K-66.3%	$296K-92.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$13.6M+10.2%	$10.4M-54.7%	$11.6M-54.3%	$4.8M-75.9%	$12.4M+20.8%	$22.9M+43.2%	$25.4M+39.1%	$19.8M+143.1%
Accounts Receivable	$2.3M-14.8%	$6.6M+560.0%	$500K-72.2%	$1.6M	$2.7M	$1.0M-44.4%	$1.8M-79.1%	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$611.3M+15.5%	$591.5M+9.4%	$566.7M+8.3%	$546.0M+5.4%	$529.3M+4.1%	$540.5M+10.0%	$523.2M+13.7%	$518.2M+8.5%
Current Liabilities	$415.0M+28.9%	$396.2M+126.9%	$371.3M+157.9%	$343.4M+159.6%	$321.9M+166.4%	$174.6M+48.1%	$144.0M+70.6%	$132.2M+15.6%
Non-Current Liabilities	$196.3M-5.3%	$195.2M-44.0%	$195.4M-48.5%	$202.6M-45.8%	$207.3M-42.4%	$348.6M-2.2%	$379.3M+0.9%	$374.1M+3.0%
Long-Term Debt	$61.7M-16.2%	$62.0M-71.4%	$63.9M-74.2%	$66.8M-72.7%	$73.6M-68.6%	$216.7M-7.5%	$247.5M-3.9%	$245.0M+11.3%
Total Equity	-$322.1M-11.4%	-$321.1M-14.4%	-$306.8M-16.3%	-$304.9M-17.7%	-$289.3M-16.2%	-$280.7M-20.9%	-$263.9M-21.6%	-$258.9M-29.5%
Retained Earnings	-$671.0M-9.8%	-$661.7M-12.6%	-$639.9M-13.7%	-$634.6M-16.1%	-$610.9M-15.5%	-$587.5M-17.6%	-$562.9M-18.4%	-$546.7M-21.5%

Not reported in any period shown, so not listed: Goodwill.

AMTX Cash Flow Statement

AMTX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$3.6M	$3.3M+109.9%	-$32.9M-338.2%	$13.8M+160.5%	-$22.9M-10.7%	-$20.6M-932.5%	$2.5M+221.9%	-$2.0M+63.1%	-$5.5M+36.6%	-$8.7M-2441.8%	$371K+147.2%	-$786K-103.8%	$20.6M+1323.5%	-$1.7M+90.1%	-$16.9M-1257.8%	-$1.2M
Depreciation & Amortization	N/A	$9.6M+14.8%	$8.4M+17.7%	$7.1M+23.7%	$5.8M+6.7%	$5.4M+10.2%	$4.9M+11.4%	$4.4M-6.8%	$4.7M-5.9%	$5.0M+4.5%	$4.8M-1.3%	$4.9M+1.1%	$4.8M+3.7%	$4.6M+52.4%	$3.0M+166.6%	$1.1M
Stock-Based Compensation	N/A	$5.8M-30.6%	$8.3M+8.5%	$7.7M+19.5%	$6.4M+63.2%	$3.9M+294.8%	$995K+28.6%	$774K-21.1%	$981K-10.9%	$1.1M+47.4%	$747K-20.4%	$938K+50.3%	$624K-64.5%	$1.8M+156.6%	$686K+287.0%	$177K
Capital Expenditures	$35.7M	$26.0M+28.4%	$20.3M-38.8%	$33.1M-15.4%	$39.2M+46.9%	$26.7M+37.8%	$19.3M+125.5%	$8.6M+110.6%	$4.1M+265.1%	$1.1M+77.4%	$629K+785.9%	$71K-96.4%	$2.0M+54.0%	$1.3M-6.7%	$1.4M-46.7%	$2.6M
Free Cash Flow	-$39.3M	-$22.7M+57.2%	-$53.2M-175.6%	-$19.3M+68.9%	-$62.0M-31.1%	-$47.3M-180.5%	-$16.9M-58.9%	-$10.6M-10.8%	-$9.6M+2.3%	-$9.8M-3700.0%	-$258K+69.9%	-$857K-104.6%	$18.6M+729.5%	-$3.0M+83.8%	-$18.3M-379.7%	-$3.8M
Investing Cash Flow	-$34.3M	-$25.6M-80.9%	-$14.1M+40.3%	-$23.7M+24.3%	-$31.3M-36.7%	-$22.9M-32.3%	-$17.3M-101.8%	-$8.6M-110.6%	-$4.1M-265.1%	-$1.1M-77.4%	-$629K-785.9%	-$71K+96.4%	-$2.0M-977.2%	$224K+101.4%	-$16.5M-1600.9%	-$968K
Financing Cash Flow	$36.9M	$26.4M-40.8%	$44.6M+390.6%	$9.1M-83.0%	$53.6M+5.8%	$50.7M+243.2%	$14.8M+46.5%	$10.1M-2.9%	$10.4M+24.1%	$8.4M+414.8%	$1.6M+99.4%	$816K+103.5%	-$23.2M-471.6%	$6.3M-81.3%	$33.3M+1687.2%	$1.9M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$7.5M	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$1.9M+67.2%	-$10.6M-6698.1%	$5.8M+145.9%	$3.1M+161.6%	-$5.7M-12.6%	$160K+101.6%	-$12.6M-137.0%	-$5.0M+19.2%
Depreciation & Amortization	$2.5M+6.4%	$2.5M+5.7%	$2.5M+15.7%	$2.4M+1.8%	$2.4M+14.3%	$2.4M+30.4%	$2.1M+19.4%	$2.3M+29.5%
Stock-Based Compensation	$1.1M-21.8%	$1.7M-26.2%	N/A	$1.4M-30.1%	$1.4M-27.5%	$2.3M-22.3%	N/A	$2.0M
Capital Expenditures	$8.5M+142.1%	$6.5M+258.8%	$16.6M+144.1%	$4.1M-8.9%	$3.5M-34.7%	$1.8M-49.1%	$6.8M-53.3%	$4.5M-48.9%
Free Cash Flow	-$10.4M-12.5%	-$17.1M-927.3%	-$10.8M+44.3%	-$1.0M+89.2%	-$9.3M+11.7%	-$1.7M+88.0%	-$19.4M-199.6%	-$9.5M+36.6%
Investing Cash Flow	-$8.5M-174.1%	-$5.1M-179.8%	-$16.6M-344.7%	-$4.1M+8.9%	-$3.1M+26.8%	-$1.8M-8.4%	-$3.7M+70.8%	-$4.5M+46.6%
Financing Cash Flow	$7.1M-29.5%	$14.7M+1073.7%	$10.0M-40.5%	$5.1M-43.3%	$10.0M+23.0%	$1.3M-88.2%	$16.8M+174.7%	$9.1M-44.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AMTX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMTX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	-0.4%-0.2pp	-0.2%	-139.3%	-2.2%-5.9pp	3.8%-2.9pp	6.7%+0.4pp	6.3%+3.1pp	3.1%+0.9pp	2.3%-5.9pp	8.1%+5.2pp	2.9%-15.0pp	17.9%+7.6pp	10.3%+15.0pp	-4.7%-8.0pp	3.3%
Operating Margin	-18.8%-3.7pp	-15.1%+33.4pp	-48.4%-35.0pp	-13.4%-5.9pp	-7.5%-3.8pp	-3.7%-1.2pp	-2.4%+3.9pp	-6.4%+1.7pp	-8.1%-7.6pp	-0.5%+5.3pp	-5.9%-17.5pp	11.6%+10.2pp	1.4%+12.6pp	-11.2%-8.0pp	-3.2%
Net Margin	-39.0%-6.3pp	-32.7%+27.4pp	-60.1%-18.1pp	-42.0%-19.8pp	-22.2%-0.1pp	-22.1%-2.6pp	-19.5%+1.6pp	-21.2%0.0pp	-21.2%-10.2pp	-10.9%+7.6pp	-18.5%-21.9pp	3.4%+17.2pp	-13.8%-11.5pp	-2.3%+10.6pp	-12.9%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-121.9%	N/A
Return on Assets	-29.6%+4.1pp	-33.8%-14.7pp	-19.1%+33.0pp	-52.0%-22.7pp	-29.3%0.0pp	-29.3%+10.2pp	-39.5%0.0pp	-39.5%-5.8pp	-33.7%-13.6pp	-20.1%+12.5pp	-32.6%-40.6pp	8.0%+33.2pp	-25.2%-20.7pp	-4.4%+62.8pp	-67.2%
Current Ratio	0.07-0.2x	0.31-0.1x	0.43+0.2x	0.21-0.1x	0.32+0.2x	0.08-0.1x	0.220.0x	0.24-0.1x	0.32+0.1x	0.260.0x	0.270.0x	0.29-0.1x	0.35+0.2x	0.12-0.1x	0.24
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	7.39	N/A
Asset Turnover	0.76-0.3x	1.03+0.7x	0.32-0.9x	1.24-0.1x	1.320.0x	1.32-0.7x	2.02+0.2x	1.87+0.3x	1.59-0.2x	1.84+0.1x	1.76-0.6x	2.33+0.5x	1.83-0.1x	1.95-3.3x	5.21
FCF Margin	-11.5%+8.4pp	-19.9%+5.1pp	-25.0%-0.8pp	-24.2%-1.9pp	-22.3%-12.1pp	-10.2%-4.9pp	-5.3%+0.3pp	-5.6%+0.9pp	-6.5%-6.3pp	-0.2%+0.4pp	-0.6%-9.6pp	9.0%+10.6pp	-1.7%+8.0pp	-9.7%-7.0pp	-2.7%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	21.6%+28.0pp	5.1%+16.9pp	-6.1%-1.7pp	-0.1%-4.9pp	-6.4%-3.7pp	-11.8%-11.0pp	-4.3%	4.8%+4.0pp
Operating Margin	9.2%+29.6pp	-11.6%+24.7pp	-5.7%+22.9pp	-14.4%-9.6pp	-20.4%0.0pp	-36.3%-23.2pp	-28.7%	-4.8%+7.7pp
Net Margin	-14.9%+29.8pp	-39.8%+17.4pp	-12.3%+22.2pp	-40.1%-18.1pp	-44.8%-0.9pp	-57.2%-23.8pp	-34.5%	-22.0%-66.7pp
Return on Assets	-3.2%+6.5pp	-8.0%+1.4pp	-2.1%+4.2pp	-9.8%-2.9pp	-9.8%+1.5pp	-9.4%-0.1pp	-6.3%	-6.9%-18.0pp
Current Ratio	0.080.0x	0.09-0.1x	0.07-0.2x	0.05-0.2x	0.06-0.1x	0.16-0.1x	0.31-0.1x	0.26-0.4x
Asset Turnover	0.220.0x	0.200.0x	0.170.0x	0.25-0.1x	0.220.0x	0.17-0.1x	0.18	0.31+0.1x
FCF Margin	-16.6%+1.1pp	-31.3%-27.4pp	-24.9%+16.3pp	-1.7%+9.9pp	-17.7%-2.0pp	-3.9%+15.2pp	-41.2%	-11.6%+10.1pp

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Note: Shareholder equity is negative (-$306.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Aemetis, Inc. (DE) AMTX	FY2025	$197.6M	-$77.0M	-39.0%	$124.1M	33/100
Flexible Solutions International, Inc. FSI	FY2025	$38.5M	$787K	2.0%	$76.6M	61/100
Future Fuel Corporation FF	FY2025	$95.7M	-$49.4M	-51.6%	$220.2M	33/100
Alto Ingredients, Inc. ALTO	FY2025	$917.9M	$13K	0.0%	$285.5M	33/100
Core Molding Technologies, Inc. CMT	FY2025	$273.8M	$11.2M	4.1%	$203.1M	58/100
5E Advanced Materials, Inc. FEAM	FY2026	N/A	-$42.9M	N/A	$134.5M	—

Where Aemetis, Inc. (DE) Ranks

Frequently Asked Questions

What is Aemetis, Inc. (DE)'s annual revenue?

Aemetis, Inc. (DE) (AMTX) reported $197.6M in total revenue for fiscal year 2025. This represents a -26.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Aemetis, Inc. (DE)'s revenue growing?

Aemetis, Inc. (DE) (AMTX) revenue declined by 26.2% year-over-year, from $267.6M to $197.6M in fiscal year 2025.

Is Aemetis, Inc. (DE) profitable?

No, Aemetis, Inc. (DE) (AMTX) reported a net income of -$77.0M in fiscal year 2025, with a net profit margin of -39.0%.

What is Aemetis, Inc. (DE)'s EBITDA?

Aemetis, Inc. (DE) (AMTX) had EBITDA of -$27.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Aemetis, Inc. (DE) have?

As of fiscal year 2025, Aemetis, Inc. (DE) (AMTX) had $4.9M in cash and equivalents against $63.9M in long-term debt.

What is Aemetis, Inc. (DE)'s gross margin?

Aemetis, Inc. (DE) (AMTX) had a gross margin of -0.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Aemetis, Inc. (DE)'s operating margin?

Aemetis, Inc. (DE) (AMTX) had an operating margin of -18.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Aemetis, Inc. (DE)'s net profit margin?

Aemetis, Inc. (DE) (AMTX) had a net profit margin of -39.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Aemetis, Inc. (DE)'s free cash flow?

Aemetis, Inc. (DE) (AMTX) recorded an outflow of $22.7M in free cash flow during fiscal year 2025. This represents a 57.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Aemetis, Inc. (DE)'s operating cash flow?

Aemetis, Inc. (DE) (AMTX) generated $3.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Aemetis, Inc. (DE)'s total assets?

Aemetis, Inc. (DE) (AMTX) had $259.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Aemetis, Inc. (DE)'s capital expenditures?

Aemetis, Inc. (DE) (AMTX) invested $26.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Aemetis, Inc. (DE) have outstanding?

Aemetis, Inc. (DE) (AMTX) had 67M shares outstanding as of fiscal year 2025.

What is Aemetis, Inc. (DE)'s current ratio?

Aemetis, Inc. (DE) (AMTX) had a current ratio of 0.07 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Aemetis, Inc. (DE)'s return on assets (ROA)?

Aemetis, Inc. (DE) (AMTX) had a return on assets of -29.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Aemetis, Inc. (DE)'s P/E ratio?

Aemetis, Inc. (DE) (AMTX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $124.1M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Aemetis, Inc. (DE)'s price-to-sales ratio?

Aemetis, Inc. (DE) (AMTX) trades at 0.6x sales, its market capitalization divided by revenue of $219.8M revenue, trailing 12 months to June 30, 2026. The market capitalization is $124.1M as of Oct 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Why is Aemetis, Inc. (DE)'s debt-to-equity ratio negative or not reported?

Aemetis, Inc. (DE) (AMTX) has negative shareholder equity of -$306.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Aemetis, Inc. (DE)'s Altman Z-Score?

Aemetis, Inc. (DE) (AMTX) has an Altman Z-Score of -4.62, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Aemetis, Inc. (DE)'s Piotroski F-Score?

Aemetis, Inc. (DE) (AMTX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Aemetis, Inc. (DE)'s earnings high quality?

Aemetis, Inc. (DE) (AMTX) reported a net loss of $77.0M while generating $3.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Aemetis, Inc. (DE) cover its interest payments?

Aemetis, Inc. (DE) (AMTX) reported an operating loss of $37.2M against $52.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Aemetis, Inc. (DE)?

Aemetis, Inc. (DE) (AMTX) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.